Vivo Opportunity Fund Holdings, L.P. 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 08:35 am Sale | 2025-03-31 | 13G | Regulus Therapeutics Inc. RGLS | Vivo Opportunity Fund Holdings, L.P. | 2,696,426 3.900% | -2,303,574 (-46.07%) | Filing |
| 2024-03-20 4:30 pm Purchase | 2024-03-14 | 13G | Regulus Therapeutics Inc. RGLS | Vivo Opportunity Fund Holdings, L.P. | 5,000,000 7.700% | 5,000,000 (New Position) | Filing |